Artiva Biotherapeutics In... (ARTV)

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

undefined

undefined%

At close: undefined

10.62

0.95%

After-hours Dec 13, 2024, 04:00 PM EST

Company Description

No Company description available at the moment.

Artiva Biotherapeutics Inc. Common Stock

Country	n/a
IPO Date	n/a
Industry	n/a
Sector	n/a
Employees	82
CEO	Dr. Fred Aslan M.D.

Contact Details

Address: No Address available No city data available,
Website	n/a

Stock Details

Ticker Symbol	n/a
Exchange	NASDAQ
Fiscal Year	n/a
Reporting Currency	n/a
CIK Code	n/a
CUSIP Number	n/a
ISIN Number	n/a
Employer ID	-
SIC Code	n/a

Key Executives

Name	Position
Dr. Fred Aslan M.D.	President, Chief Executive Officer & Director
Jennifer Kinsbruner Bush Esq., J.D.	Executive Vice President, Chief Operating Officer, Chief Legal Officer, Corporate Secretary & Compliance Officer
Neha Krishnamohan	Chief Financial Officer & Executive Vice President of Corporate Development
Christopher P. Horan	Chief Technical Operations Officer
Dr. David Moriarty Ph.D.	Senior Vice President of Clinical Operations
Dr. Heather Raymon Ph.D.	Senior Vice President of Research & Early Development
Dr. Peter Flynn Ph.D.	Co-Founder & Strategic Advisor
Dr. Thorsten Graef M.D., Ph.D.	Chief Medical Officer
Javier Coindreau M.D.	Senior Vice President of Medical Affairs

Latest SEC Filings

No SEC filings available.

View All SEC Filings